Related Experiment Video
Updated: Jun 26, 2026
07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Pediatric follicular lymphoma: a rare clinicopathologic entity
1Department of Pathology and Laboratory Medicine, Loma Linda University Medical Center, Loma Linda, CA 92354, USA. reagrawal@llu.edu
Archives of Pathology & Laboratory Medicine
|January 7, 2009
Summary
Pediatric follicular lymphoma, though rare, shows a better prognosis than adult cases, with children often diagnosed at lower stages and responding well to treatment. Distinguishing it from reactive hyperplasia is key for accurate diagnosis and management.
Area of Science:
- Pediatric Oncology
- Hematology
- Pathology
Background:
- Follicular lymphoma is common in adults but rare in children.
- Pediatric follicular lymphoma exhibits a more favorable prognosis compared to adult follicular lymphoma, despite often being higher grade.
- Children with follicular lymphoma are typically diagnosed at lower clinical stages.
Purpose of the Study:
- To highlight pediatric follicular lymphoma as a unique clinicopathologic entity.
- To emphasize the favorable prognosis and distinct characteristics of pediatric follicular lymphoma.
- To guide the accurate diagnosis and management of pediatric follicular lymphoma.
Main Methods:
- Distinguishing pediatric follicular lymphoma from reactive follicular hyperplasia.
- Utilizing immunohistochemical and molecular markers for diagnosis.
- Careful attention to clinical and morphologic details.
Main Results:
- Pediatric follicular lymphoma generally has a better survival rate than adult follicular lymphoma.
- Children with follicular lymphoma respond well to less aggressive therapies.
- Pediatric follicular lymphoma may represent a subset with an exceptionally good prognosis.
Conclusions:
- Pediatric follicular lymphoma is a distinct entity requiring specific diagnostic and management approaches.
- Early recognition and accurate diagnosis are crucial for optimal patient outcomes.
- The favorable prognosis in children underscores the need for tailored treatment strategies.
Related Concept Videos
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:15Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...